IL232905A - Non-coagulant glycosaminoglycans that include a repeat discharged unit and their medical use - Google Patents

Non-coagulant glycosaminoglycans that include a repeat discharged unit and their medical use

Info

Publication number
IL232905A
IL232905A IL232905A IL23290514A IL232905A IL 232905 A IL232905 A IL 232905A IL 232905 A IL232905 A IL 232905A IL 23290514 A IL23290514 A IL 23290514A IL 232905 A IL232905 A IL 232905A
Authority
IL
Israel
Prior art keywords
coagulative
glycosaminoglycans
medical use
disaccharide unit
repeating disaccharide
Prior art date
Application number
IL232905A
Other languages
English (en)
Hebrew (he)
Other versions
IL232905A0 (en
Original Assignee
Dilafor Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=48668970&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL232905(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Dilafor Ab filed Critical Dilafor Ab
Publication of IL232905A0 publication Critical patent/IL232905A0/en
Publication of IL232905A publication Critical patent/IL232905A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0075—Heparin; Heparan sulfate; Derivatives thereof, e.g. heparosan; Purification or extraction methods thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/727—Heparin; Heparan
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/04—Drugs for genital or sexual disorders; Contraceptives for inducing labour or abortion; Uterotonics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/06—Antiabortive agents; Labour repressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Biochemistry (AREA)
  • Materials Engineering (AREA)
  • Polymers & Plastics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Gynecology & Obstetrics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
IL232905A 2011-12-19 2014-06-01 Non-coagulant glycosaminoglycans that include a repeat discharged unit and their medical use IL232905A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201161577223P 2011-12-19 2011-12-19
PCT/SE2012/051433 WO2013095279A1 (en) 2011-12-19 2012-12-19 Non anti-coagulative glycosaminoglycans comprising repeating disaccharide unit and their medical use

Publications (2)

Publication Number Publication Date
IL232905A0 IL232905A0 (en) 2014-07-31
IL232905A true IL232905A (en) 2017-02-28

Family

ID=48668970

Family Applications (1)

Application Number Title Priority Date Filing Date
IL232905A IL232905A (en) 2011-12-19 2014-06-01 Non-coagulant glycosaminoglycans that include a repeat discharged unit and their medical use

Country Status (28)

Country Link
US (1) US9475888B2 (enExample)
EP (1) EP2794665B1 (enExample)
JP (2) JP6543467B2 (enExample)
KR (1) KR102135485B1 (enExample)
CN (1) CN104144950B (enExample)
AU (1) AU2012354229B2 (enExample)
BR (1) BR112014014454B1 (enExample)
CA (1) CA2856492C (enExample)
CL (1) CL2014001651A1 (enExample)
CO (1) CO7061069A2 (enExample)
CY (1) CY1119899T1 (enExample)
DK (1) DK2794665T3 (enExample)
ES (1) ES2656613T3 (enExample)
HR (1) HRP20180124T1 (enExample)
HU (1) HUE036523T2 (enExample)
IL (1) IL232905A (enExample)
LT (1) LT2794665T (enExample)
ME (1) ME02994B (enExample)
MX (1) MX351104B (enExample)
NO (1) NO2904345T3 (enExample)
PL (1) PL2794665T3 (enExample)
PT (1) PT2794665T (enExample)
RS (1) RS56874B1 (enExample)
RU (1) RU2617764C2 (enExample)
SI (1) SI2794665T1 (enExample)
SM (1) SMT201800143T1 (enExample)
WO (1) WO2013095279A1 (enExample)
ZA (1) ZA201403640B (enExample)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013095215A1 (en) 2011-12-19 2013-06-27 Dilaforette Ab Low anticoagulant heparins
EP2830635A4 (en) * 2012-03-26 2016-03-16 Dilafor Ab COMBINATION TREATMENT OF ILLUSTRATED SULFATED GLYCOSAMINOGLYCANES
CN104244957B (zh) * 2012-03-26 2017-11-17 迪乐方有限责任公司 用于治疗分娩停止的方法
UA117912C2 (uk) * 2012-05-08 2018-10-25 Ділафор Аб Застосування гепарину або гепарансульфату для лікування післяпологової кровотечі (ппк)
GB2515315A (en) * 2013-06-19 2014-12-24 Dilafor Ab New Processes
CN103788222B (zh) * 2014-01-08 2016-08-31 中国科学院昆明植物研究所 Fuc3S4S取代的低聚糖胺聚糖及其制备方法
EP3137509A4 (en) * 2014-04-30 2018-03-14 Agency For Science, Technology And Research Heparan sulphates
CN108424474B (zh) * 2017-02-15 2023-07-25 清华大学 去抗凝肝素衍生物及其用于炎症性肠病的治疗
UA129730C2 (uk) 2020-02-17 2025-07-16 Дилафор Аб Тафоксипарин для лікування прееклампсії
EP4272749A1 (en) 2022-05-03 2023-11-08 Dilafor AB New medical use of tafoxiparin
JP2025514038A (ja) 2022-05-03 2025-05-02 ディラフォール アクチエボラグ タフォキシパリンの新規な医学的使用
GB202407366D0 (en) * 2024-05-23 2024-07-10 Glycos Biomedical Ltd Preparation of medium molecular weight heparin

Family Cites Families (53)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1136620A (en) 1979-01-08 1982-11-30 Ulf P.F. Lindahl Heparin fragments having selective anticoagulation activity
JPS63246396A (ja) * 1987-03-31 1988-10-13 Shiseido Co Ltd モノクロ−ナル抗体
FR2614026B1 (fr) * 1987-04-16 1992-04-17 Sanofi Sa Heparines de bas poids moleculaire, a structure reguliere, leur preparation et leurs applications biologiques
SE9002550D0 (sv) * 1990-08-01 1990-08-01 Kabivitrum Ab Heparinfragment
SE9003181D0 (sv) 1990-10-04 1990-10-04 Kabivitrum Ab Use of heparin fraction
US5250519A (en) 1991-03-29 1993-10-05 Glycomed Incorporated Non-anticoagulant heparin derivatives
US5280016A (en) 1991-03-29 1994-01-18 Glycomed Incorporated Non-anticoagulant heparin derivatives
JPH0532703A (ja) * 1991-07-26 1993-02-09 Terumo Corp 低分子量ヘパリン誘導体の製造法
AU5442594A (en) * 1992-10-13 1994-05-09 Virginia Commonwealth University Use of non-anticoagulant heparin for treating ischemia/reperfusion injury
US5527785A (en) 1993-05-14 1996-06-18 The Regents Of The University Of California Selectin receptor modulating compositions
US5744457A (en) * 1995-03-31 1998-04-28 Hamilton Civic Hospitals Research Development Inc. Compositions and methods for inhibiting thrombogenesis
ATE224918T1 (de) * 1995-03-31 2002-10-15 Hamilton Civic Hospitals Res Zusammensetzung zur hemmung der thromboseentstehung
US5993810A (en) 1996-03-15 1999-11-30 Lebovitz; Shamir Israel Method of softening or ripening the cervix of a female mammal using collagenase
US5767269A (en) * 1996-10-01 1998-06-16 Hamilton Civic Hospitals Research Development Inc. Processes for the preparation of low-affinity, low molecular weight heparins useful as antithrombotics
WO1998016559A1 (fr) 1996-10-15 1998-04-23 Toray Industries, Inc. Agent de maturation des canaux cervicaux
GB9711443D0 (en) * 1997-06-03 1997-07-30 Leo Pharm Prod Ltd Chemical suppositions
JP3342007B2 (ja) * 1997-11-20 2002-11-05 郁男 山科 低分子ヘパリン修飾体及び皮膚潰瘍治療剤
US6596705B1 (en) 1998-02-09 2003-07-22 The Regents Of The University Of California Inhibition of L-selectin and P-selection mediated binding using heparin
US6498246B1 (en) 1998-02-26 2002-12-24 Seikagaku Corporation Glycosaminoglycan derivatives and processes for preparing same
US6028061A (en) 1998-06-18 2000-02-22 Children's Medical Center Corp Angiogenesis inhibitors and use thereof
EP1022289B1 (en) * 1998-07-31 2004-07-07 Seikagaku Corporation Novel glycosaminoglycan and drug compositions containing the same
JP2002523522A (ja) * 1998-08-26 2002-07-30 ザ コラボレイティブ グループ，リミテッド． 非誘導化水溶性ベータ−（１，３）−グルカンのレセプター
MXPA02000142A (es) * 1999-06-30 2003-07-21 Hamilton Civic Hospitals Res Composiciones de heparina que inhiben los factores de coagulacion asociados con el coagulo.
JP4897991B2 (ja) * 1999-07-23 2012-03-14 ラボラトリオス ファルマセウティコス ロビ ソシエダッド アノニマ 超低分子量ヘパリン組成物
IT1316986B1 (it) 2000-01-25 2003-05-26 Sigma Tau Ind Farmaceuti Derivati glicosamminoglicani parzialmente desolfatati nonanticoagulanti ad attivita' antiangiogenica.
JP4585072B2 (ja) * 2000-02-29 2010-11-24 扶桑薬品工業株式会社 ヘパリン解重合法、解重合ヘパリン、その誘導体および医薬組成物
DK1319183T3 (da) * 2000-09-12 2009-05-18 Massachusetts Inst Technology Fremgangsmåder og produkter relateret til heparin med lav molekylvægt
SE521676C2 (sv) 2002-01-02 2003-11-25 Dilafor Ab Användning av glykosaminoglykaner för prevention och behandling av värksvaghet vid fullgången graviditet
US20040072796A1 (en) 2002-04-18 2004-04-15 Embury Stephen H. Method and composition for preventing pain in sickle cell patients
US8071569B2 (en) 2002-09-20 2011-12-06 Mousa Shaker A Oxidized heparin fractions and their use in inhibiting angiogenesis
JP2005106694A (ja) * 2003-09-30 2005-04-21 Mochida Pharmaceut Co Ltd 敗血症早期検出及び重篤度評価
EP1582531A1 (en) 2004-03-24 2005-10-05 Aventis Pharma S.A. Process for oxidizing unfractionated heparins and detecting presence or absence of glycoserine in heparin and heparin products
US20060040896A1 (en) * 2004-08-18 2006-02-23 Paringenix, Inc. Method and medicament for anticoagulation using a sulfated polysaccharide with enhanced anti-inflammatory activity
US7741311B2 (en) 2005-01-03 2010-06-22 Shaker Mousa Composition and method for treating occlusive vascular diseases, nerve regeneration, and wound healing
MX2008000974A (es) * 2005-07-22 2008-03-27 Univ California Composiciones de heparina e inhibicion de selectina.
WO2007014155A2 (en) 2005-07-22 2007-02-01 Trf Pharma, Inc. Method for treating sickle cell disease and sickle cell disease sequelae
AU2007233320B2 (en) * 2006-04-04 2013-12-12 Singulex, Inc. Highly sensitive system and methods for analysis of troponin
CN101495517B (zh) * 2006-05-25 2012-10-10 莫曼塔医药品有限公司 低分子量肝素及其用途
WO2009007224A1 (en) 2007-07-10 2009-01-15 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Low molecular weight heparin derivatives having neuroprotective activity
EP2205642B1 (en) 2007-11-02 2016-01-27 Momenta Pharmaceuticals, Inc. Non-anticoagulant polysaccharide compositions
US8592393B2 (en) * 2007-11-02 2013-11-26 Momenta Pharmaceuticals, Inc. Polysaccharide compositions and methods of use for the treatment and prevention of disorders associated with progenitor cell mobilization
US8569262B2 (en) 2007-11-02 2013-10-29 Momenta Pharmaceuticals, Inc. Polysaccharide compositions and methods of use for the treatment and prevention of disorders associated with progenitor cell mobilization
WO2009059283A1 (en) * 2007-11-02 2009-05-07 Momenta Pharmaceuticals, Inc. Non-anticoagulant polysaccharide compositions
US8445436B2 (en) 2007-12-03 2013-05-21 Florida State University Research Foundation, Inc. Oxytocin and melatonin compositions and associated methods for inducing labor
CN102177180A (zh) 2008-04-04 2011-09-07 犹他州大学研究基金会 烷基化半合成的糖胺聚糖醚及其制备和使用方法
WO2010111570A1 (en) * 2009-03-27 2010-09-30 E. I. Du Pont De Nemours And Company Polyglycerol aldehydes
EP2419736B1 (en) 2009-04-16 2014-01-29 Momenta Pharmaceuticals, Inc. Methods of assessing activity of a polysaccharide composition
US20120108538A1 (en) 2009-06-30 2012-05-03 James Beeson Sulfated polysaccharides having antiplasmodial activity and methods and products for identifying antiplasmodial activity
CA2769258A1 (en) * 2009-07-31 2011-02-03 Bayer Healthcare Llc Modified factor ix polypeptides and uses thereof
BR112012015029A2 (pt) * 2009-12-22 2017-06-27 Lifebond Ltd matriz reticulada, método para controlar a formação de uma matriz, método ou matriz, método para vedar um tecido contra vazamento de um fluído corporal, agente hemostático ou vedante cirúrgico, composição para vedar um ferimento, uso da composição, composição para um veículo para entrega localizada de fármaco, composição para engenharia de tecido, e método para modificar uma composição
WO2013095215A1 (en) 2011-12-19 2013-06-27 Dilaforette Ab Low anticoagulant heparins
CN104244957B (zh) 2012-03-26 2017-11-17 迪乐方有限责任公司 用于治疗分娩停止的方法
EP2830635A4 (en) 2012-03-26 2016-03-16 Dilafor Ab COMBINATION TREATMENT OF ILLUSTRATED SULFATED GLYCOSAMINOGLYCANES

Also Published As

Publication number Publication date
RU2014129816A (ru) 2016-02-20
EP2794665A1 (en) 2014-10-29
ME02994B (me) 2018-10-20
ZA201403640B (en) 2017-06-28
HRP20180124T1 (hr) 2018-02-23
MX2014007122A (es) 2015-03-05
AU2012354229A1 (en) 2014-06-05
PL2794665T3 (pl) 2018-04-30
HK1202883A1 (en) 2015-10-09
DK2794665T3 (da) 2018-01-29
IL232905A0 (en) 2014-07-31
RU2617764C2 (ru) 2017-04-26
US20150011505A1 (en) 2015-01-08
KR20140113652A (ko) 2014-09-24
MX351104B (es) 2017-10-02
BR112014014454A2 (pt) 2017-06-13
JP2018111825A (ja) 2018-07-19
CO7061069A2 (es) 2014-09-19
CA2856492C (en) 2017-01-10
KR102135485B1 (ko) 2020-07-17
RS56874B1 (sr) 2018-04-30
LT2794665T (lt) 2017-12-27
ES2656613T3 (es) 2018-02-27
EP2794665B1 (en) 2017-11-22
SI2794665T1 (en) 2018-03-30
JP6543467B2 (ja) 2019-07-10
CL2014001651A1 (es) 2014-10-10
WO2013095279A1 (en) 2013-06-27
US9475888B2 (en) 2016-10-25
SMT201800143T1 (it) 2018-05-02
PT2794665T (pt) 2018-01-24
EP2794665A4 (en) 2015-08-26
JP2015500388A (ja) 2015-01-05
CN104144950B (zh) 2017-09-05
CN104144950A (zh) 2014-11-12
CA2856492A1 (en) 2013-06-27
BR112014014454B1 (pt) 2021-03-09
HUE036523T2 (hu) 2018-07-30
AU2012354229B2 (en) 2016-12-01
CY1119899T1 (el) 2018-06-27
NO2904345T3 (enExample) 2018-07-21

Similar Documents

Publication Publication Date Title
IL232905A (en) Non-coagulant glycosaminoglycans that include a repeat discharged unit and their medical use
EP2797512A4 (en) MEDICAL DEVICES FOR ASSESSING IMAGE SUPPORT AND PROCEDURE
IL234628A0 (en) Imidazolyl-pyrimidines are converted into amino-indolyl and their use as drugs
PL2403854T3 (pl) Sulfonylowane tetrahydroazolopirazyny i ich zastosowanie jako produktów leczniczych
EP2563426A4 (en) APPLICATION WITH HIGH SCAM FOR MEDICAL THERAPY
IL221511A (en) Arilatriazolones associated with bis aryl and their use
GB201120345D0 (en) Medical console
GB201010193D0 (en) Medicinal use
ZA201208173B (en) Peptices and their use
EP2797944A4 (en) COMPOSITIONS COMPRISING C5 AND C6 OLIGOSACCHARIDES
EP2718283A4 (en) INDAZOLE AND PYRROLOPYRIDINE DERIVATIVE AND PHARMACEUTICAL USE THEREOF
EP2740728A4 (en) URACIL DERIVATIVE AND ITS USE FOR MEDICAL PURPOSES
IL228433A0 (en) Pyridopyrazine history and their use
ZA201405039B (en) Pharmaceutical preparation comprising brexpiprazole and substituted beta - cyclodextrin
EP2730230A4 (en) ULTRASOUND UNIT AND ULTRASOUND ENDOSCOPE
IL232824A0 (en) Medical and/or diagnostic nanocarriers targeting mmp
IL232174A0 (en) Preparations containing a salt of a sodium channel inhibitor and their uses
PL2582733T3 (pl) Polimery z bocznymi grupami sacharydowymi i ich zastosowanie
IL232239A0 (en) Medical use
EP2893881A4 (en) ULTRASOUND UNIT AND ULTRASOUND ENDOSCOPE
IL223707A0 (en) N-hydroxyformamide derivative and medicament containing same
SI2536400T1 (sl) Zdravilo, ki vsebuje miramistin
EP2859852A4 (en) ULTRASONIC UNIT AND ULTRASOUND DOSCOPE
GB201215502D0 (en) Medical use
ZA201304369B (en) Use of glycosaminoglycan lipote esters in the trichology field

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed